Northern Trust Corp Incyte Corp Transaction History

Northern Trust Corp

$586 Billion
Q2 2024

A detailed history of Northern Trust Corp transactions in Incyte Corp stock. As of the latest transaction made, Northern Trust Corp holds 1,813,119 shares of INCY stock, worth $119 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,813,119

Previous 1,850,967 2.04%

Holding current value

$119 Million

Previous $105 Million 4.23%

% of portfolio

0.02%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$51.18 - $63.75 $1.94 Million - $2.41 Million	-37,848 Reduced 2.04%	1,813,119 $110 Million
Q1 2024 May 14, 2024	SELL	$56.55 - $66.59 $7.38 Million - $8.69 Million	-130,528 Reduced 6.59%	1,850,967 $105 Million
Q4 2023 Feb 13, 2024	SELL	$52.16 - $64.19 $7.63 Million - $9.38 Million	-146,193 Reduced 6.87%	1,981,495 $124 Million
Q3 2023 Nov 13, 2023	BUY	$57.77 - $65.93 $6.9 Million - $7.87 Million	119,389 Added 5.94%	2,127,688 $123 Million
Q2 2023 Aug 11, 2023	SELL	$60.95 - $75.51 $4.48 Million - $5.55 Million	-73,459 Reduced 3.53%	2,008,299 $125 Million
Q1 2023 May 15, 2023	BUY	$70.23 - $86.01 $6 Million - $7.35 Million	85,461 Added 4.28%	2,081,758 $150 Million
Q4 2022 Feb 13, 2023	BUY	$67.18 - $84.11 $4.17 Million - $5.23 Million	62,134 Added 3.21%	1,996,297 $160 Million
Q3 2022 Nov 14, 2022	SELL	$66.18 - $82.86 $4.22 Million - $5.28 Million	-63,738 Reduced 3.19%	1,934,163 $129 Million
Q2 2022 Aug 12, 2022	BUY	$66.18 - $83.18 $1.19 Million - $1.5 Million	18,009 Added 0.91%	1,997,901 $152 Million
Q1 2022 May 13, 2022	SELL	$66.02 - $79.71 $1.79 Million - $2.16 Million	-27,095 Reduced 1.35%	1,979,892 $157 Million
Q4 2021 Feb 08, 2022	BUY	$63.34 - $74.11 $1.61 Million - $1.89 Million	25,489 Added 1.29%	2,006,987 $147 Million
Q3 2021 Nov 15, 2021	BUY	$68.67 - $84.02 $2.81 Million - $3.43 Million	40,880 Added 2.11%	1,981,498 $136 Million
Q2 2021 Aug 13, 2021	SELL	$79.87 - $87.53 $1.52 Million - $1.66 Million	-18,993 Reduced 0.97%	1,940,618 $163 Million
Q1 2021 May 12, 2021	SELL	$76.02 - $100.5 $3.02 Million - $3.99 Million	-39,744 Reduced 1.99%	1,959,611 $159 Million
Q4 2020 Feb 11, 2021	SELL	$80.74 - $97.7 $7.74 Million - $9.37 Million	-95,899 Reduced 4.58%	1,999,355 $174 Million
Q3 2020 Nov 16, 2020	BUY	$85.07 - $109.69 $2.37 Million - $3.06 Million	27,889 Added 1.35%	2,095,254 $188 Million
Q2 2020 Aug 14, 2020	BUY	$74.18 - $108.93 $3.54 Million - $5.19 Million	47,680 Added 2.36%	2,067,365 $215 Million
Q1 2020 May 14, 2020	BUY	$63.18 - $85.97 $2.19 Million - $2.98 Million	34,706 Added 1.75%	2,019,685 $148 Million
Q4 2019 Feb 14, 2020	SELL	$73.04 - $95.72 $7.27 Million - $9.52 Million	-99,471 Reduced 4.77%	1,984,979 $173 Million
Q3 2019 Nov 13, 2019	SELL	$72.82 - $86.52 $4.83 Million - $5.74 Million	-66,295 Reduced 3.08%	2,084,450 $155 Million
Q2 2019 Aug 13, 2019	BUY	$73.52 - $88.7 $9.99 Million - $12.1 Million	135,914 Added 6.75%	2,150,745 $183 Million
Q1 2019 May 13, 2019	BUY	$63.56 - $88.17 $2.63 Million - $3.65 Million	41,396 Added 2.1%	2,014,831 $173 Million
Q4 2018 Feb 12, 2019	BUY	$58.5 - $69.94 $3.68 Million - $4.4 Million	62,842 Added 3.29%	1,973,435 $125 Million
Q3 2018 Nov 14, 2018	SELL	$61.75 - $74.23 $572,731 - $688,483	-9,275 Reduced 0.48%	1,910,593 $132 Million
Q2 2018 Sep 18, 2018	SELL	$60.85 - $83.98 $835,409 - $1.15 Million	-13,729 Reduced 0.71%	1,919,868 $129 Million
Q2 2018 Aug 14, 2018	BUY	$60.85 - $83.98 $3.91 Million - $5.4 Million	64,282 Added 3.44%	1,933,597 $130 Million
Q1 2018 May 09, 2018	BUY	$83.06 - $100.98 $17,276 - $21,003	208 Added 0.01%	1,869,315 $156 Million
Q4 2017 Feb 14, 2018	SELL	$93.56 - $116.6 $2.09 Million - $2.6 Million	-22,296 Reduced 1.18%	1,869,107 $177 Million
Q3 2017 Nov 13, 2017	BUY	$109.15 - $138.27 $206 Million - $262 Million	1,891,403	1,891,403 $221 Million

Others Institutions Holding INCY

# of Institutions

629

Shares Held

198M

Call Options Held

766K

Put Options Held

476K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $14.6B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Incyte Corp Transaction History